A citation-based method for searching scientific literature

Krzysztof Ksiazek, João F Passos, Sharon Olijslagers, Gabriele Saretzki, Carmen Martin-Ruiz, Thomas von Zglinicki. Biochem Biophys Res Commun 2007
Times Cited: 37







List of co-cited articles
225 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression.
Ermira Pazolli, Elise Alspach, Agnieszka Milczarek, Julie Prior, David Piwnica-Worms, Sheila A Stewart. Cancer Res 2012
86
2

Epithelial-to-Mesenchymal Transition and Migration of Human Peritoneal Mesothelial Cells Undergoing Senescence.
Edyta Kawka, Janusz Witowski, Pilar Sandoval, Andras Rudolf, Angela Rynne Vidal, Manuel Lopez Cabrera, Achim Jörres. Perit Dial Int 2019
3
33

Reactive oxygen species generation is essential for cisplatin-induced accelerated senescence in hepatocellular carcinoma.
Kai Qu, Ting Lin, Zhixin Wang, Sinan Liu, Hulin Chang, Xinsen Xu, Fandi Meng, Lei Zhou, Jichao Wei, Minghui Tai,[...]. Front Med 2014
23
4


Deciphering the Molecular Mechanism of Spontaneous Senescence in Primary Epithelial Ovarian Cancer Cells.
Martyna Pakuła, Ewa Mały, Paweł Uruski, Anna Witucka, Małgorzata Bogucka, Natalia Jaroszewska, Nicoletta Makowska, Arkadiusz Niklas, Rafał Moszyński, Stefan Sajdak,[...]. Cancers (Basel) 2020
5
20

Dose response of carboplatin-induced hearing loss in rats: antioxidant defense system.
K Husain, R B Scott, C Whitworth, S M Somani, L P Rybak. Hear Res 2001
28
3

Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. N Engl J Med 2012
960
2

Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.
Zehua Wang, Jianwen Gao, Yuko Ohno, Haiou Liu, Congjian Xu. Cancer Chemother Pharmacol 2020
4
25




Bystander senescence in human peritoneal mesothelium and fibroblasts is related to thrombospondin-1-dependent activation of transforming growth factor-β1.
Justyna Mikuła-Pietrasik, Patrycja Sosińska, Jędrzej Janus, Błażej Rubiś, Marta Brewińska-Olchowik, Katarzyna Piwocka, Krzysztof Książek. Int J Biochem Cell Biol 2013
20
5

Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
Hilary A Kenny, Chun-Yi Chiang, Erin A White, Elizabeth M Schryver, Mohammed Habis, Iris L Romero, Andras Ladanyi, Carla V Penicka, Joshy George, Karl Matlin,[...]. J Clin Invest 2014
144
2


Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.
Annekatrin Lukanova, Rudolf Kaaks. Cancer Epidemiol Biomarkers Prev 2005
192
2

Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies.
Gwo Yaw Ho, Natasha Woodward, Jermaine I G Coward. Crit Rev Oncol Hematol 2016
88
2

Protecting the normal in order to better kill the cancer.
Bingya Liu, Lewis Ezeogu, Lucas Zellmer, Baofa Yu, Ningzhi Xu, Dezhong Joshua Liao. Cancer Med 2015
30
3

A Unique Pattern of Mesothelial-Mesenchymal Transition Induced in the Normal Peritoneal Mesothelium by High-Grade Serous Ovarian Cancer.
Martyna Pakuła, Paweł Uruski, Arkadiusz Niklas, Aldona Woźniak, Dariusz Szpurek, Andrzej Tykarski, Justyna Mikuła-Pietrasik, Krzysztof Książek. Cancers (Basel) 2019
6
16

Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence.
Hubert Fleury, Nicolas Malaquin, Véronique Tu, Sophie Gilbert, Aurélie Martinez, Marc-Alexandre Olivier, Alexandre Sauriol, Laudine Communal, Kim Leclerc-Desaulniers, Euridice Carmona,[...]. Nat Commun 2019
36
2

Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity.
Yuchen Chien, Claudio Scuoppo, Xiaowo Wang, Xueping Fang, Brian Balgley, Jessica E Bolden, Prem Premsrirut, Weijun Luo, Agustin Chicas, Cheng S Lee,[...]. Genes Dev 2011
440
2

Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.
S Zhang, I Mercado-Uribe, Z Xing, B Sun, J Kuang, J Liu. Oncogene 2014
185
2


Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer.
J S Rader, R J Neuman, J Brady, S Babb, S Temple, E Kost, D G Mutch, T J Herzog. Obstet Gynecol 1998
9
11

Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells.
Yue Wang, Jie Yang, Yan Gao, Yongrui Du, Leyuan Bao, Wenyan Niu, Zhi Yao. Cell Mol Immunol 2005
40
2

Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine.
Monique B Nilsson, Robert R Langley, Isaiah J Fidler. Cancer Res 2005
215
2

PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis.
Valerie S LeBleu, Joyce T O'Connell, Karina N Gonzalez Herrera, Harriet Wikman, Klaus Pantel, Marcia C Haigis, Fernanda Machado de Carvalho, Aline Damascena, Ludmilla Thome Domingos Chinen, Rafael M Rocha,[...]. Nat Cell Biol 2014
610
2

Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
Masato Yoshihara, Hiroaki Kajiyama, Akira Yokoi, Mai Sugiyama, Yoshihiro Koya, Yoshihiko Yamakita, Wenting Liu, Kae Nakamura, Yoshinori Moriyama, Hiroaki Yasui,[...]. Int J Cancer 2020
5
20


From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors.
Avi Ashkenazi, Wayne J Fairbrother, Joel D Leverson, Andrew J Souers. Nat Rev Drug Discov 2017
323
2

Illicit survival of cancer cells during polyploidization and depolyploidization.
I Vitale, L Galluzzi, L Senovilla, A Criollo, M Jemaà, M Castedo, G Kroemer. Cell Death Differ 2011
94
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.